Is Mounjaro Safe to Take While Pregnant?

You've just found out you're pregnant and Mounjaro is in the fridge door

It's a moment that catches many people off guard. You opened the fridge this morning for the pen you were due to use this week, and a positive test has changed everything. The answer here is unambiguous: stop the injection, put the pen back, and call your GP or midwife today.

Mounjaro is not suitable for use in pregnancy. That's not a cautious hedge, it's the licensed position. The Mounjaro Summary of Product Characteristics on the eMC states that tirzepatide should not be used during pregnancy because preclinical studies in animals identified potential foetal harm at clinically relevant doses. Human pregnancy data is extremely limited; the safety profile simply has not been established in this population.

Tirzepatide's mechanism, slowing gastric emptying and altering nutrient absorption alongside appetite regulation, raises additional theoretical questions about nutritional supply to a developing pregnancy, though these remain unquantified in human studies. What matters practically is that no benefit-risk calculation supports continuing the medicine once pregnancy is confirmed. The decision is not yours or your prescriber's to weigh differently, the licence does not permit it.

If you were prescribed Mounjaro through a private Mounjaro service and are unsure how to pause your treatment formally, contact the prescribing pharmacy as well as your GP so both records are updated.

Trying to conceive: when Mounjaro should be stopped in advance

The picture is equally clear if you are planning a pregnancy. You should not begin trying to conceive while on tirzepatide, and current guidance recommends stopping treatment before you start trying. The exact wash-out window needed before conception is not firmly established in published data, so this is a conversation to have with your GP or a specialist rather than one to estimate yourself.

There is an additional layer worth knowing about. Women taking oral contraceptives alongside Mounjaro face a specific absorption consideration: because tirzepatide slows gastric emptying, the pill's absorption may be reduced during the first four weeks of starting treatment and for four weeks after each dose increase. NHS England's guidance on weight-management injections recommends adding a non-oral method of contraception, such as condoms, during those windows. If your contraception was oral-only during those periods and there is any possibility of pregnancy, a test is sensible before doing anything else.

There is no evidence that weight loss achieved before conception is harmful; for many people, reaching a healthier weight before pregnancy is clinically beneficial. The question of when to stop and how long to wait is the one to put to your clinical team, because it depends on individual circumstances that a prescriber can assess. You can read more about broader Mounjaro side effects and safety considerations in a fuller guide.

What happens to your weight management plan during and after pregnancy

Stopping Mounjaro does not mean abandoning the progress you have made. Appetite regulation and dietary habits built during treatment often carry forward to some degree, though this varies. Your clinical team, particularly a midwife or obstetric dietitian, can advise on appropriate nutritional targets for pregnancy alongside any weight management goals.

After pregnancy, breastfeeding presents a further pause. Tirzepatide is not recommended while breastfeeding; it is not known whether the medicine passes into breast milk in amounts that could affect a nursing infant, and the precautionary position is to avoid it until you have finished breastfeeding entirely.

Once breastfeeding is complete, Mounjaro can be reconsidered if you remain clinically eligible and your circumstances have not changed in ways that affect suitability. That assessment starts fresh, a prescriber reviews your current health, weight, and any relevant changes since you last took the medicine. If you want to understand what general safety considerations apply when resuming Mounjaro, that page covers the broader picture. For questions specific to kidney function or other organ-level safety queries that sometimes arise post-pregnancy, the guide on tirzepatide and kidney safety may also be relevant. If you are considering whether a tablet-based formulation might suit you better on resumption, our page covering what to expect from oral tirzepatide side effects is worth reading alongside your prescriber conversation. For a detailed look at whether Mounjaro is safe for pregnant women, that dedicated guide brings together the clinical evidence in one place.

At nume (at nume) every repeat prescription involves a fresh clinical review. A named GPhC-registered prescriber reads your updated answers before any treatment is issued; no repeat goes out on autopilot. When the time is right to restart, speak to our prescribers and they will assess your situation from scratch.